Pharmagellan Guide to Analyzing Biotech Clinical Trials

If you work in the biotech industry, understanding clinical trial results is essential. However, many professionals feel out of their comfort zone when reading journal articles, press releases, or investor presentations because they lack deep expertise in study design or biostatistics. The Pharmagellan Guide to Analyzing Biotech Clinical Trials serves as a comprehensive primer designed specifically for non-experts. This book provides a structured roadmap to help you evaluate clinical studies of new therapies with confidence. It offers clear explanations of the most common concepts and terms used in biotech clinical studies, making it an essential resource for anyone needing to assess the main components of planned or completed biotech trials.